Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Ziemssen, Tjalf; Groth, Marie; Winkelmann, Veronika et al.
AMA-VACC: Clinical trial assessing the immune response to SARS-CoV-2 mRNA vaccines and booster vaccination in siponimod treated patients with secondary progressive multiple sclerosisNEUROLOGY. Bd. 100. H. 17. 2023
Tenaglia, Albano H. H.; Lujan, Lucas A. A.; Rios, Diego N. N. et al.
Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lambliaNATURE COMMUNICATIONS. Bd. 14. H. 1. 2023
Lutfullin, Isabel; Eveslage, Maria; Bittner, Stefan et al.
Association of obesity with disease outcome in multiple sclerosisJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. Bd. 94. H. 1. 2023 S. 57-61
Timaru-Kast, Ralph; Coronel-Castello, Shila P.; Kraemer, Tobias J. et al.
AT 1 inhibition mediated neuroprotection after experimental traumatic brain injury is dependent on neutrophils in male miceSCIENTIFIC REPORTS. Bd. 13. H. 1. 2023
Pape, Katrin; Protopapa, Maria; Schraad, Muriel et al.
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaFRONTIERS IN ONCOLOGY. Bd. 13. 2023
Backer, Ronald A.; Probst, Hans Christian; Clausen, Bjoern E.
Classical DC2 subsets and monocyte-derived DC: Delineating the developmental and functional relationshipEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 53. H. 3. 2023
Sassmannshausen, Juliane; Bennink, Sandra; Distler, Ute et al.
Comparative proteomics of vesicles essential for the egress of<i> Plasmodium</i><i> falciparum</i> gametocytes from red blood cellsMOLECULAR MICROBIOLOGY. 2023
Pielenhofer, JS; Meiser, L; Gogoll, K et al.
Complaint management of a quality defect in a nanoparticulate Imiquimod formulation in an investigator initiated academic phase I/II clinical trial Part 1Pharmazeutische Industrie. Bd. 85. 2023 S. 182-6
Pielenhofer, JS; Meiser, L; Gogoll, K et al.
Complaint management of a quality defect in a nanoparticulate imiquimod formulation in an investigator initiated academic phase I/II clinical trial, part 2Pharmazeutische Industrie. Bd. 85. 2023 S. 294-299
Lakus, J.; Backer, R. A.; Eich, C. et al.
Constitutive stabilization of beta-catenin in CD11c+cells alleviates allergic asthmaALLERGOLOGIE. Bd. 46. H. 2. 2023 S. 135-135